| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Ackrell Capital
|
Featured in report |
5
|
1 |
This page from an Ackrell Capital report details the 'Infused Products' segment of the cannabis industry, breaking down sales by category for Q3 2017 in Colorado, Oregon, and Washington. It specifically highlights 'Edibles,' explaining their manufacturing, consumption methods, metabolic processes, and distinct physiological effects compared to inhalation.
This document is page 47 of a 2017 report by Ackrell Capital, LLC regarding 'Cannabis Industry Segmentation.' It provides a technical overview of cannabis concentrates, specifically comparing solvent-based (hydrocarbon, CO2, ethanol) and solvent-free extraction methods. It includes market data from Q3 2017 for Colorado, Oregon, and Washington provided by BDS Analytics. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional document production, the text contains no references to Jeffrey Epstein, associates, or specific financial transactions.
This page from an Ackrell Capital report discusses the potential first FDA approval of a cannabis-derived pharmaceutical (Epidiolex) in 2018 and its implications. It also analyzes the commoditization of cannabis flower, noting a downward pricing trend in legalized states like Colorado, Oregon, and Washington, illustrated by a graph of prices from 2016 to 2017.
This document is page 140 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It profiles four companies in the cannabis industry: Auntie Dolores, Baker Technologies, BAS Research, and BDS Analytics. The document bears a Bates stamp 'HOUSE_OVERSIGHT_024776', indicating it is part of a document production to the House Oversight Committee, likely related to financial investigations, though no direct mention of Jeffrey Epstein appears on this specific page.
This document is page 138 from a December 2017 Cannabis Investment Report produced by Ackrell Capital. It lists the 'Top 100 Private Cannabis Companies' for 2018, categorized alphabetically across four columns. The document bears a 'HOUSE_OVERSIGHT_024774' stamp, indicating it is part of a House Oversight Committee investigation file.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity